Registry of patients with inflammatory and autoimmune diseases with SARS-CoV2 infection
- Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
- Total publications:0 publications
Grant number: COV20_01138
Grant search
Key facts
Disease
COVID-19Funder
National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)Principal Investigator
Ricardo Blanco Alonso, Miguel Ángel González-GayResearch Location
SpainLead Research Institution
FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA (IDIVAL)Research Priority Alignment
N/A
Research Category
Epidemiological studies
Research Subcategory
Disease susceptibility
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The project tries to generate a registry of all patients diagnosed with SARS-CoV2 infection and previously diagnosed rheumatological disease. To do this, EHR data will be collected from SARS-CoV2 + patients and rheumatological diseases in relation to their underlying disease, their previous treatment, the treatment that was being used when the symptoms of infection began, the course of the disease until its resolution, including the appearance of complications, the therapies used as treatment and the presence of risk factors. The objective is to subsequently analyze the data obtained in order to determine what is the influence of rheumatological diseases in the course of infection and if the therapies administered can be beneficial or harmful in terms of prophylaxis and / or less or greater severity of the disease. infection.